Search by Drug Name or NDC
NDC 33342-0447-15 Pyrazinamide 500 mg/1 Details
Pyrazinamide 500 mg/1
Pyrazinamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is PYRAZINAMIDE.
MedlinePlus Drug Summary
Pyrazinamide kills or stops the growth of certain bacteria that cause tuberculosis (TB). It is used with other drugs to treat tuberculosis. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 33342-0447-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pyrazinamide
Product Information
| NDC | 33342-0447 |
|---|---|
| Product ID | 33342-447_3695f057-de86-4c9a-9d43-ff0a6acdffe7 |
| Associated GPIs | 09000070000310 |
| GCN Sequence Number | 009424 |
| GCN Sequence Number Description | pyrazinamide TABLET 500 MG ORAL |
| HIC3 | W2E |
| HIC3 Description | ANTI-MYCOBACTERIUM AGENTS |
| GCN | 41790 |
| HICL Sequence Number | 004084 |
| HICL Sequence Number Description | PYRAZINAMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Pyrazinamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Pyrazinamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | PYRAZINAMIDE |
| Labeler Name | Macleods Pharmaceuticals Limited |
| Pharmaceutical Class | Antimycobacterial [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212541 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 33342-0447-15 (33342044715)
| NDC Package Code | 33342-447-15 |
|---|---|
| Billing NDC | 33342044715 |
| Package | 500 TABLET in 1 BOTTLE (33342-447-15) |
| Marketing Start Date | 2020-07-27 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.83157 |
| Pricing Unit | EA |
| Effective Date | 2022-10-19 |
| NDC Description | PYRAZINAMIDE 500 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis